The acquisition is a small bolt-on that should modestly boost revenue and margins. No debt or equity issuance was used. Monitor the Q3 2026 10-Q (due by Oct 15) for integration details and margin impact. The deal does not change UTMD's core strategy but provides a stable, accretive revenue stream.
Price Chart
Executive Summary
UTMD's UK subsidiary Femcare Ltd acquired all shares of Orion Medical Supplies Ltd for 3.6 million in cash. Orion is a niche harm-reduction device assembler/distributor; the deal is expected to add ~$6M to UTMD's annual sales and be accretive by leveraging existing Femcare infrastructure. The acquisition is small relative to UTMD's $232M market cap but uses cash reserves with no dilution.
Key Facts
- Purchase price of 3.6 million paid from cash reserves
- Expected to add about $6 million to UTMD's consolidated annual sales
- Orion is a UK-based assembler/distributor of harm reduction medical devices
- Acquisition is not synergistic from a medical use perspective but is accretive via overhead leverage
- Orion's operations will move into Femcare's existing Romsey facilities after a transition period
Financial Impact
Adds ~$6M to annual revenue (approx. 10-12% of current sales) for a cash purchase price of 3.6M; accretive due to overhead dilution
Risk Factors
- Integration risk as Orion's harm reduction products are not synergistic with UTMD's existing device portfolio
- Potential distraction from core business during facility move and transition
- Limited growth upside given the niche market and retiring founders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001096906-26-001326 |
| Document: utmd_ex99z1.htm | 0001096906-26-001326 |
| Document: 0001096906-26-001326-index-headers.html | 0001096906-26-001326 |
| Document: 0001096906-26-001326-index.html | 0001096906-26-001326 |
| Document: 0001096906-26-001326.txt | 0001096906-26-001326 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 4w ago | 8-K | $71.13 $74.95 | ▲ +5.37% | ▲ +5.56% | $74.31 (+4.47%) |
Jul 23, 2026 10w ago | 8-K | $64.18 $71.42 | ▼ −11.28% | ▼ −7.97% | $74.31 (−15.78%) |
Apr 23, 2026 23w ago | 8-K | $67.87 $64.17 | ▲ +5.45% | ▲ +10.09% | $74.31 (−9.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access